VAC Bioburden Wound Care Assessment
Does Negative Pressure Wound Therapy With Instillation Reduce the Bioburden of Infections of the Upper and Lower Extremity?
Sponsor: 3M
A NA clinical study on Lower Extremity Wound and Soft Tissue Abscesses, this trial is terminated or withdrawn. The trial is conducted by 3M and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2023 — Jul 2024 [monthly]
Terminated NA
-
Sep 2023 — Dec 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Mar 2023 — Sep 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2023 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2022 — Jan 2023 [monthly]
Recruiting NA
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- 3M
- Duke University
For direct contact, visit the study record on ClinicalTrials.gov .